Costa, L <br/><br/>
Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Dec 2007 
 - S16-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0960-9776 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2007.10.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density Conservation Agents--therapeutic use<br/>Bone Neoplasms--complications<br/>Breast Neoplasms--pathology<br/>Diphosphonates--therapeutic use<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Fractures, Bone--etiology<br/>Humans<br/>Imidazoles--therapeutic use<br/>Neoplasm Staging<br/>Osteoporosis--etiology<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome<br/>Zoledronic Acid